Welcome to LookChem.com Sign In|Join Free
  • or
Phosphinic acid, [4-(4-fluorophenyl)butyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

109635-75-8

Post Buying Request

109635-75-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

109635-75-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 109635-75-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,6,3 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 109635-75:
(8*1)+(7*0)+(6*9)+(5*6)+(4*3)+(3*5)+(2*7)+(1*5)=138
138 % 10 = 8
So 109635-75-8 is a valid CAS Registry Number.

109635-75-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-fluorophenyl)butyl-hydroxy-oxophosphanium

1.2 Other means of identification

Product number -
Other names [4-(4-fluorophenyl)butyl]phosphinic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:109635-75-8 SDS

109635-75-8Relevant academic research and scientific papers

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]- -proline, a novel orally active inhibitor of ACE

Karanewsky,Badia,Cushman,DeForrest,Dejneka,Loots,Perri,Petrillo Jr.,Powell

, p. 204 - 212 (2007/10/02)

The synthesis of a series of orally active, phosphinyloxyacyl proline inhibitors of angiotensin converting enzyme (ACE) is described. The in vitro and in vivo ACE inhibitory activities are reported for each compound. The structure-activity relationship fo

ORALLY ACTIVE PHOSPHONYL HYDROXYACYL PROLINES

-

, (2008/06/13)

This invention is directed to orally active antihypertensive agents of the formula STR1 wherein R 1 is certain alkyl or aralkyl groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 109635-75-8